242 related articles for article (PubMed ID: 32804906)
1. Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data.
Ramos Boluda E; Redecillas Ferreiro S; Manrique Moral O; García Romero R; Irastorza Terradillos I; Nuñez Ramos R; Germán Díaz M; Polo Miquel B; Vives Piñera I; Alcolea Sánchez A; González Sacristán R; Bautista Barea M; Moreno Villares JM
J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):734-739. PubMed ID: 32804906
[TBL] [Abstract][Full Text] [Related]
2. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B; O'Keefe SJ
Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
[TBL] [Abstract][Full Text] [Related]
4. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
Lam K; Schwartz L; Batisti J; Iyer KR
JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
Ukleja A; To C; Alvarez A; Lara LF
JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H
J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
[TBL] [Abstract][Full Text] [Related]
7. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
Iyer KR; Kunecki M; Boullata JI; Fujioka K; Joly F; Gabe S; Pape UF; Schneider SM; Virgili Casas MN; Ziegler TR; Li B; Youssef NN; Jeppesen PB
JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study.
Kocoshis SA; Merritt RJ; Hill S; Protheroe S; Carter BA; Horslen S; Hu S; Kaufman SS; Mercer DF; Pakarinen MP; Venick RS; Wales PW; Grimm AA
JPEN J Parenter Enteral Nutr; 2020 May; 44(4):621-631. PubMed ID: 31495952
[TBL] [Abstract][Full Text] [Related]
9. The Variable Response to Teduglutide in Pediatric Short Bowel Syndrome: A Single Country Real-Life Experience.
Guz-Mark A; Hino B; Berkowitz D; Hartman C; Millman PN; Orlanski-Meyer E; Shaoul R; Spector-Cohen I; Weiss B; Zangen T; Shamir R
J Pediatr Gastroenterol Nutr; 2022 Sep; 75(3):293-298. PubMed ID: 35730756
[TBL] [Abstract][Full Text] [Related]
10. Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide-9 Years of Follow-Up.
Zaczek Z; Jurczak-Kobus P; Panczyk M; Braszczyńska-Sochacka J; Majewska K; Kunecki M; Dąbrowska K; Sobocki J
Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458196
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
[TBL] [Abstract][Full Text] [Related]
12. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
Joly F; Seguy D; Nuzzo A; Chambrier C; Beau P; Poullenot F; Thibault R; Armengol Debeir L; Layec S; Boehm V; Lallemand J; Quilliot D; Schneider SM
Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048
[TBL] [Abstract][Full Text] [Related]
13. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
Kochar B; Herfarth HH
Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
[TBL] [Abstract][Full Text] [Related]
14. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
[TBL] [Abstract][Full Text] [Related]
15. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
Jeppesen PB; Pertkiewicz M; Messing B; Iyer K; Seidner DL; O'keefe SJ; Forbes A; Heinze H; Joelsson B
Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
[TBL] [Abstract][Full Text] [Related]
16. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
Seidner DL; Fujioka K; Boullata JI; Iyer K; Lee HM; Ziegler TR
Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
[TBL] [Abstract][Full Text] [Related]
17. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
[TBL] [Abstract][Full Text] [Related]
18. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
Chen K; Mu F; Xie J; Kelkar SS; Olivier C; Signorovitch J; Jeppesen PB
JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
[TBL] [Abstract][Full Text] [Related]
19. New approaches to the treatments of short bowel syndrome-associated intestinal failure.
Jeppesen PB
Curr Opin Gastroenterol; 2014 Mar; 30(2):182-8. PubMed ID: 24406477
[TBL] [Abstract][Full Text] [Related]
20. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
